Antitumor activities of the targeted multi-tyrosine kinase inhibitor lenvatinib (E7080) against RET gene fusion-driven tumor models

JOURNAL ARTICLE published October 2013 in Cancer Letters

Authors: Kiyoshi Okamoto | Kotaro Kodama | Kazuma Takase | Naoko Hata Sugi | Yuji Yamamoto | Masao Iwata | Akihiko Tsuruoka